Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

155
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
155
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

218
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
218
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

155
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
155
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

210
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
210
Breathing01:05

Breathing

59.1K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026
Same author

Loss of Y Chromosome Associates With Lung and Cardiac Dysfunction in COPD.

Comprehensive Physiology·2026
Same author

Bronchodilator reversibility, body plethysmographic phenotypes, and mortality in patients with COPD or PRISm.

The European respiratory journal·2026
Same author

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA.

Therapeutic advances in respiratory disease·2026
Same author

Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET.

International journal of chronic obstructive pulmonary disease·2026
Same author

Electrocardiogram-based detection of an atrial cardiomyopathy predicts postoperative supraventricular arrhythmias after lung transplantation.

JTCVS open·2025

Related Experiment Video

Updated: Jun 25, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.7K

[Alpha 1-antitrypsin deficiency].

Sebastian Fähndrich1, Robert Bals2

  • 1Klinik für Pneumologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität, Killianstraße 5, 79106, Freiburg, Deutschland. sebastian.faehndrich@uniklinik-freiburg.de.

Innere Medizin (Heidelberg, Germany)
|May 24, 2024
PubMed
Summary

Alpha 1-antitrypsin (AAT) deficiency is a genetic disorder requiring multidisciplinary care. Understanding its epidemiology, genetics, symptoms, diagnostics, and treatment is crucial for early recognition and improved patient outcomes.

Keywords:
Liver diseasesLung diseasesMutationProtease inhibitorTherapeutic substitution

More Related Videos

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

2.2K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.3K

Related Experiment Videos

Last Updated: Jun 25, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.7K
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

2.2K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.3K

Area of Science:

  • Genetics
  • Pulmonology
  • Internal Medicine

Background:

  • Alpha 1-antitrypsin (AAT) deficiency is a complex inherited disorder.
  • It requires a multidisciplinary clinical approach for effective management.
  • A comprehensive understanding is vital for patient care.

Purpose of the Study:

  • To provide an overview of AAT deficiency.
  • To cover epidemiology, genetics, symptoms, diagnostics, and treatment.
  • To emphasize the importance of knowledge for early recognition and improved quality of life.

Main Methods:

  • Literature review.
  • Synthesis of current knowledge on AAT deficiency.
  • Overview of diagnostic and therapeutic strategies.

Main Results:

  • AAT deficiency presents with diverse clinical manifestations.
  • Early diagnosis and targeted interventions improve patient outcomes.
  • Interdisciplinary collaboration is key to managing the condition.

Conclusions:

  • In-depth knowledge of AAT deficiency is essential for healthcare professionals.
  • Optimizing quality of life for affected individuals requires early recognition and targeted treatment.
  • Continued research and education are necessary to combat AAT deficiency effectively.